September 10, 2009 in City

Reward in OxyContin robberies up to $2,000

By The Spokesman-Review
Courtesy of Crime Stoppers photo

Spokane police and Crime Stoppers are offering a reward for information leading to the arrest of this man in the robbery of a Rite Aid pharmacy at 4514 S. Regal St. about 5:40 p.m. Sept. 5.
(Full-size photo)(All photos)

The reward for information that helps capture a suspected two-time pharmacy robbery is now up to $2,000.

The company that makes OxyContin is offering the money through Crime Stoppers in hopes of finding the man police suspect robbed two pharmacies of the powerful painkiller in two weeks.

The robberies occurred Aug. 24 at the Shopko at 4515 S. Regal St., and Sept. 5 at the Rite Aid across the street, 4514 S. Regal St.

In each case, a white man who appeared to be wearing a wig handed an employee a note demanding OxyContin, then fled with the drug.

Rite Aid surveillance photos released today show the robber in a white shirt, blue jeans and a white beanie-style hat over a dark wig. Witnesses said he was 6-foot-2 and had fake facial hair.

Shopko surveillance photos show the robber wore sunglasses, a black T-shirt, blue jeans, white sneakers and a dark baseball hat with a white logo. Witnesses said he was about 6-foot-3.

Anyone with information is asked to call Crime Stoppers at (800) 222-TIPS, or submit tips online at Tipsters do not have to leave a name but should provide a code name or number.

Based in Stamford, Conn., Purdue Pharma introduced OxyContin to the prescription drug market in 1996 and has been fined for lying about its addictiveness.

In 2003, the company created a program, RxPatrol, to help police and pharmacies track prescription drug robberies.

Get stories like this in a free daily email

Please keep it civil. Don't post comments that are obscene, defamatory, threatening, off-topic, an infringement of copyright or an invasion of privacy. Read our forum standards and community guidelines.

You must be logged in to post comments. Please log in here or click the comment box below for options.

comments powered by Disqus